• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E-钙黏蛋白、VEGF、COX-2 表达与甲状腺乳头状癌预后参数的相关性。

Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma.

机构信息

Department of Pathology, Duzce University of Medical Faculty, Duzce, Turkey.

出版信息

Exp Mol Pathol. 2011 Jun;90(3):312-7. doi: 10.1016/j.yexmp.2011.01.008. Epub 2011 Feb 16.

DOI:10.1016/j.yexmp.2011.01.008
PMID:21335003
Abstract

Thyroid cancer represents approximately 1% of all human malignancies. papillary thyroid carcinoma (PTC) is the most common malignant tumor of the thyroid gland, accounting for 70-80% of all thyroid cancers. In the US, the incidence of thyroid cancer is 4 per 100,000 individuals. It is two to four times as frequent in women as in men. The development of PTC is influenced by many factors including genetic alterations, growth factors, and physical agents such as radiation. In order to recognize the prognosis for PTC, a lot of clinic and pathological parameters such as; age, tumor size, extra-thyroid tumor spread, lymph node, distant metastases, gender, tumor stage are used. As most of these parameters are subjective, more objective and useful prognostic factors are needed for determining biologic behavior, providing an initial assessment. In this study, we aimed to compare the expressions of COX-2, E-cadherin, VEGF to classical prognostic factors, and to investigate the correlation with prognosis. Operation records from 79 PTC cases were examined retrospectively. In the study, we aimed to investigate the whole tissue by means of stereology method, which is an impartial one, and we indicated the expression COX-2, VEGF, E-cadherin immunohistochemically in 79 resection diagnosed with PTC. We determined correlations between the expressions of COX-2 and VEGF, E-cadherin, and age, gender, and stage.

摘要

甲状腺癌约占所有人类恶性肿瘤的 1%。甲状腺乳头状癌 (PTC) 是甲状腺最常见的恶性肿瘤,占所有甲状腺癌的 70-80%。在美国,甲状腺癌的发病率为每 10 万人中有 4 人。女性的发病率是男性的两到四倍。PTC 的发展受到许多因素的影响,包括遗传改变、生长因子和物理因素如辐射。为了识别 PTC 的预后,使用了大量的临床和病理参数,如年龄、肿瘤大小、甲状腺外肿瘤扩散、淋巴结、远处转移、性别、肿瘤分期。由于这些参数大多是主观的,因此需要更客观和有用的预后因素来确定生物学行为,提供初步评估。在这项研究中,我们旨在比较 COX-2、E-cadherin、VEGF 与经典预后因素的表达,并研究与预后的相关性。回顾性检查了 79 例 PTC 病例的手术记录。在研究中,我们旨在通过立体学方法对整个组织进行研究,这是一种公正的方法,并通过免疫组织化学方法检测 79 例经手术诊断为 PTC 的 COX-2、VEGF、E-cadherin 的表达。我们确定了 COX-2 和 VEGF、E-cadherin 的表达与年龄、性别和分期之间的相关性。

相似文献

1
Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma.E-钙黏蛋白、VEGF、COX-2 表达与甲状腺乳头状癌预后参数的相关性。
Exp Mol Pathol. 2011 Jun;90(3):312-7. doi: 10.1016/j.yexmp.2011.01.008. Epub 2011 Feb 16.
2
VEGF-C and COX-2 expression in papillary thyroid cancer.血管内皮生长因子C和环氧化酶-2在甲状腺乳头状癌中的表达
Endocr Relat Cancer. 2006 Jun;13(2):465-73. doi: 10.1677/erc.1.01114.
3
Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.甲状腺乳头状癌中血管内皮生长因子C表达增加与颈部淋巴结转移相关。
Clin Cancer Res. 2005 Nov 15;11(22):8063-9. doi: 10.1158/1078-0432.CCR-05-0646.
4
[Expression of COX-2 and VEGF-C in papillary thyroid carcinoma and their relationship to cervical lymph metastases].[COX-2和VEGF-C在甲状腺乳头状癌中的表达及其与颈部淋巴结转移的关系]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009 Oct;23(19):881-3.
5
[Multifocal papillary thyroid carcinoma: clinical analysis of 168 cases].[多灶性甲状腺乳头状癌:168例临床分析]
Zhonghua Wai Ke Za Zhi. 2009 Mar 15;47(6):450-3.
6
Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma.侵袭性甲状腺乳头状癌中血管内皮生长因子的表达。
Thyroid. 2009 Nov;19(11):1233-7. doi: 10.1089/thy.2008.0179.
7
[Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].[血管内皮生长因子、血管内皮生长因子-C及血管内皮生长因子-D在甲状腺乳头状癌中的表达及意义]
Ai Zheng. 2005 Sep;24(9):1136-9.
8
Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.血管内皮生长因子(VEGF)表达与环氧化酶-2(COX-2)、微血管密度及人胃癌临床病理特征的相关性及其预后意义
Ann Surg Oncol. 2007 Oct;14(10):2738-47. doi: 10.1245/s10434-007-9484-7. Epub 2007 Aug 9.
9
Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer.黑色素瘤相关抗原的表达与人类甲状腺癌的进展相关。
Endocr Relat Cancer. 2009 Jun;16(2):455-66. doi: 10.1677/ERC-09-0002. Epub 2009 Mar 4.
10
Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.血清血管内皮生长因子C与甲状腺乳头状癌的淋巴结转移及高危肿瘤特征相关。
Ann Surg. 2008 Mar;247(3):483-9. doi: 10.1097/SLA.0b013e31815fa447.

引用本文的文献

1
Role of epithelial-mesenchymal markers in predicting metastasis of papillary thyroid carcinoma: A retrospective case-control study.上皮-间质标志物在预测甲状腺乳头状癌转移中的作用:一项回顾性病例对照研究。
Qatar Med J. 2025 Jun 30;2025(2):45. doi: 10.5339/qmj.2025.45. eCollection 2025.
2
BRAF regulates circPSD3/miR-526b/RAP2A axis to hinder papillary thyroid carcinoma progression.BRAF通过调节环状PSD3/miR-526b/RAP2A轴来抑制甲状腺乳头状癌的进展。
BMC Mol Cell Biol. 2025 Jan 21;26(1):6. doi: 10.1186/s12860-024-00528-2.
3
Case report: A rare case of breast and multiorgan metastases secondary to papillary thyroid carcinoma.
病例报告:1例罕见的继发于甲状腺乳头状癌的乳腺及多器官转移病例。
Front Oncol. 2024 Nov 4;14:1422817. doi: 10.3389/fonc.2024.1422817. eCollection 2024.
4
High COX-2 immunostaining in papillary thyroid carcinoma is associated with adverse survival outcomes.在甲状腺乳头状癌中,COX-2 免疫染色高与不良生存结局相关。
Ann Saudi Med. 2022 Nov-Dec;42(6):359-365. doi: 10.5144/0256-4947.2022.359. Epub 2022 Dec 1.
5
Ginsenoside Rh2 inhibits thyroid cancer cell migration and proliferation via activation of miR-524-5p.人参皂苷Rh2通过激活miR-524-5p抑制甲状腺癌细胞的迁移和增殖。
Arch Med Sci. 2020 Feb 11;18(1):164-170. doi: 10.5114/aoms.2020.92871. eCollection 2022.
6
Prognostic Significance of COX-2 Overexpression in -Mutated Middle Eastern Papillary Thyroid Carcinoma.COX-2 过表达在 -突变型中东地区甲状腺乳头状癌中的预后意义。
Int J Mol Sci. 2020 Dec 14;21(24):9498. doi: 10.3390/ijms21249498.
7
Aberrant Expression of Androgen Receptor Associated with High Cancer Risk and Extrathyroidal Extension in Papillary Thyroid Carcinoma.雄激素受体异常表达与甲状腺乳头状癌的高癌症风险及甲状腺外侵犯相关。
Cancers (Basel). 2020 Apr 29;12(5):1109. doi: 10.3390/cancers12051109.
8
Thyroid volumes and serum VEGF levels in dyslipidemic patients: effects of statin treatment.血脂异常患者的甲状腺体积和血清 VEGF 水平:他汀类药物治疗的影响。
Turk J Med Sci. 2019 Jun 18;49(3):738-745. doi: 10.3906/sag-1708-106.
9
Reduced expression of oestrogen receptor-β is associated with tumour invasion and metastasis in oestrogen receptor-α-negative human papillary thyroid carcinoma.雌激素受体-β表达降低与雌激素受体-α阴性人甲状腺乳头状癌的肿瘤侵袭和转移相关。
Int J Exp Pathol. 2018 Feb;99(1):15-21. doi: 10.1111/iep.12266. Epub 2018 Apr 14.
10
miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.微小RNA-622通过直接靶向甲状腺乳头状癌中的血管内皮生长因子A抑制肿瘤形成。
Onco Targets Ther. 2018 Mar 16;11:1501-1509. doi: 10.2147/OTT.S156810. eCollection 2018.